Sanofi winthrop industrie

Index
Globenewswire

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid

Globenewswire

Press Release: Dupixent Approved as the First-ever Biologic Medicine in Japan for Patients with COPD